We’ve all heard of Ozempic by now. It’s only licensed for use as an injectable diabetes treatment in the UK and US, but it’s widely used ‘off label’ to help people lose weight. So much so in fact, tha

Lighter doesn’t always mean faster. Rob Kemp investigates why muscle and fuelling matter much more than the number on the scales

From personalised treatments to new AI-powered tools, diabetes care is undergoing a revolution. We explain how to make recent developments work for you

Q I’ve heard low-carbohydrate diets help with fat burning: do I really need carbs? AIt’s a common question, and the answer is a confident yes, especially if you’re a woman who runs. Carbohydrates are

Around 2.5 million people are currently taking weight-loss drugs in the UK. That’s almost 3.5% of the population injecting drugs such as Mounjaro and WeGovy and facing up to access barriers, price fluctuations and supply shortages. But, as four men explain, the hype around these drugs is very real

MULTIPLYING WEIGHT-LOSS MEDS WHEN MIKE DOUSTDAR STARTED AS A SUMMER EMPLOYEE making copies at Novo Nordisk—a teenager living in Austria after fleeing unrest in his home country of Iran at 12—he never